Aaron G. Mammoser

Aaron G. Mammoser

Neurology | Neurosurgery
2001 Peachtree Road NE
Suite 645
Atlanta, GA 30309

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

CRE25-043: Treatment of HER2-Positive Breast Cancer With Leptomeningeal Metastases With Intrathecal Trastuzumab.

CRE25-043: Treatment of HER2-Positive Breast Cancer With Leptomeningeal Metastases With Intrathecal Trastuzumab.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025

A pilot survey into the landscape of neuro-oncology care in the community.

A pilot survey into the landscape of neuro-oncology care in the community.

Journal: The oncologist
Published: October 01, 2024

Sex Difference in Disease-Related Adverse Events Post-Diagnosis of Lung Cancer Brain Metastases in Medicare Individuals ≥ 66 Years of Age.

Sex Difference in Disease-Related Adverse Events Post-Diagnosis of Lung Cancer Brain Metastases in Medicare Individuals ≥ 66 Years of Age.

Journal: Cancers
Published: July 23, 2024

Recurrent high grade serous endometrial cancer with brain metastases: Immunotherapy confers improved quality of life and survival.

Recurrent high grade serous endometrial cancer with brain metastases: Immunotherapy confers improved quality of life and survival.

Journal: Gynecologic oncology reports
Published: July 16, 2024

Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series.

Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series.

Journal: British journal of neurosurgery
Published: June 08, 2023

Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.

Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.

Journal: The Lancet. Oncology
Published: May 23, 2023

Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting.

Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting.

Journal: Neuro-oncology practice
Published: November 17, 2022

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.

Journal: Cell reports. Medicine
Published: September 14, 2022

Delivering Equitable Care to Underserved Neuro-oncology Populations.

Delivering Equitable Care to Underserved Neuro-oncology Populations.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 08, 2021

BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases.

BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases.

Journal: International journal of radiation oncology, biology, physics
Published: August 22, 2019

Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.

Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.

Journal: Cancer
Published: May 30, 2018

Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical Trial.

Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical Trial.

Journal: Translational oncology
Published: December 01, 2015
Showing 1-12 of 17

Last Updated: 09/26/2026